50 likes | 61 Views
Data Bridge Market Research analyses a growth rate in the global keloid treatment market in the forecast period 2022-2029. The expected CAGR of global keloid treatment market is tend to be around 3.50% in the mentioned forecast period. The market was valued at USD 3.50 billion in 2021, and it would grow upto USD 4.61 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epi
E N D
Global Keloid Treatment Market – Industry Trends and Forecast to 2029 The global keloid treatment market is expected to witness significant growth during the forecast period. Keloid scarring affects people of all age groups, even though dark-skinned people are more vulnerable, with 6% to 16% of African populations suffering from keloid skin disorders. Clinics and hospitals adopt many modern therapy alternatives as the demand for keloid treatment develops. Sudden outbreak of the COVID-19 pandemic imposed stringent lockdown regulations globally, causing interruptions in import and export activities of global keloid treatment market. Data Bridge Market Research analyses a growth rate in the global keloid treatment market in the forecast period 2022-2029. The expected CAGR of global keloid treatment market is tend to be around 3.50% in the mentioned forecast period. The market was valued at USD 3.50 billion in 2021, and it would grow upto USD 4.61 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. https://www.databridgemarketresearch.com/reports/global-keloid-treatment-market
Report Description Keloid is also known as keloidal scar, defined as the firm, rubbery lesions or shiny, dense fibrous nodules scars that appear anywhere on the body. It is caused by the large production of protein in the skin during healing. These are unevenly shaped scars that appear on the skin and grow in size over time. This disease prevalence is rising and important diagnostic procedures and treatments will boost the growth of the market. Drivers Increased burn Injuries As per the records of WHO, around 180,000 deaths because of burn incidence are recorded annually, wherein the majority of incidents are recorded in low- and middle-income countries. For instance, according to the National Health Portal of India, about 7 million people yearly suffer from burn injuries. Thus, the global keloid treatment market is estimated to boost with increasing burn cases during the forecast period. Technological Advancements There has been technological advancement in this market that boost the business margin. The launch of laser therapies for treatment and elimination of scars is extensively being adopted. Furthermore, numerous companies are introducing new laser therapy products in this regard. For instance, Cynosure launched a new generation MedLite C6, a Q-switched laser therapy device used to treat skin diseases. https://www.databridgemarketresearch.com/toc/?dbmr=global-keloid-treatment-market
Market Segmentation • Product Type • Elastic Wraps • Sprays • Ointment • Creams • Oils, • Topical Gels & Gel Sheets • Others • Treatment Type • Radiation Therapy • Surgical Intervention • Steroid Injections • Others • Clinics • Others • https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-keloid-treatment-market
Key Players • Key players operating in the global keloid treatment market include: • F. Hoffmann-La Roche Ltd. (Switzerland) • Mylan N.V. (U.S.) • Pfizer Inc. (U.S.) • GSK plc (U.K.) • Novartis AG (Switzerland) • AstraZeneca (U.K.) • Sun Pharmaceutical Industries Ltd. (India) • Merck & Co., Inc. (U.S.) • Bristol-Myers Squibb Company (U.S.) • Lilly (U.S.) • Revitol (U.S.) • Renovo Group plc (U.K.) • AVITA Medical (U.S.
About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com